Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

January 31, 1994

Primary Completion Date

January 31, 2003

Study Completion Date

January 31, 2003

Conditions
Ovarian CancerTesticular Germ Cell Tumor
Interventions
BIOLOGICAL

filgrastim

DRUG

cisplatin

DRUG

ifosfamide

DRUG

paclitaxel

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER